Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 03:38:00 14/02/26 am AEDT			5-day change	1st Jan Change
45.98 ^EUR	+0.65%		+0.40%	+24.25%

13/02	China Promises German Companies Fair Competitive Conditions	RE
13/02	China holds roundtable meeting with German companies	RE

U.S. Supreme Court agrees to hear Bayer's bid to limit lawsuits filed under state laws over its weedkiller Roundup

Published on 01/17/2026 at 06:32 am AEDT

Reuters

Latest news about Bayer AG

13/02	China Promises German Companies Fair Competitive Conditions	RE
13/02	China holds roundtable meeting with German companies	RE
12/02	Pharma companies left out of Trump's drug-pricing deals look for way in	RE
12/02	Major U-turns on corporate splits in recent years	RE
12/02	Pharma companies left out of Trump's drug-pricing deals look for way in	RE
12/02	Major U-turns on corporate splits over the years	RE
12/02	Major U-turns on corporate splits in recent years	RE
11/02	German drugmakers lobby says US price rules will challenge domestic market	RE
11/02	German drugmakers lobby says US price rules will challenge domestic market	RE
09/02	BAYER AG : Goldman Sachs reiterates its Buy rating	ZD
07/02	Bayer Cleared to Offer Stryax After EPA Registers Dicamba Herbicides	DJ
07/02	BAYER AG : Gets a Buy rating from Barclays	ZD
07/02	Bayer Hesitates to Raise Sales Forecast Despite Asundexian Breakthrough	RE
07/02	Bayer Aktiengesellschaft - Special Call
07/02	Bayer confident in asundexian but too early to comment on specific peak sales numbers	RE

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.6%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.2%), Switzerland (1.2%), Europe/Middle East/Africa (23.6%), the United States (31.7%), North America (3.6%), China (7.7%), Asia/Pacific (9.6%), Brazil (9.3%) and Latin America (8.1%).

Employees

88,502

Sector

Pharmaceuticals

Calendar

24/04 - Annual General Meeting

More about the company